AlloCure Inc., a biotechnology company at the forefront of innovative cell therapies for the treatment of acute kidney injury, today announced the closing of a $14.5MM Series A financing. AlloCure is poised to become the first company to commercialize effective cell therapies to treat various kidney diseases, organ transplants, multi-organ injury and a number of […]
Less
More
Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today announced the initial close of Series A financing at $5.35 million. Histogen will utilize the round to fund Phase 1 clinical trials for hair growth and complete 510k submissions for wound and hernia repair applications. Histogen, launched in 2007, […]
Aldagen, Inc. today announced it has raised $18.4 million in a private round of financing. Aldagen is a biopharmaceutical company developing proprietary regenerative cell therapies that target significant unmet medical needs. The company has four product candidates in clinical trials. Aldagen’s most advanced product candidate, ALD-101, is currently in a pivotal Phase III clinical trial […]
Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company and a leading developer of oncology compounds directed to cancer stem cell targets, today announced that it has completed a $12.5 million round of financing. Stemline Therapeutics, Inc. is a clinical stage biotechnology company developing novel oncology compounds directed to cancer stem cell targets. Stemline’s lead compound, […]
Fate Therapeutics, a new biotechnology company developing drugs to control cell fate, has raised $12 million.  Fate will harness the healing power of adult stem cells by using small molecule drugs to modulate cells in vivo (in the body) and by reprogramming mature adult cells into stem cells. “Fate’s approach is the dawn of a new […]
Plasticell raises $516,000. Plasticell is a developer of regenerative small molecule drugs using high throughput stem cell technologies. Plasticell aims to develop drugs by elucidating the biochemical mechanisms that control the proliferation and differentiation of stem cells, the master cells responsible for tissue development and repair. Plasticell also forms alliances with industry partners to produce […]
Aldagen, Inc., a biotechnology company advancing a pipeline of clinical stage regenerative therapies, today announced it has raised an additional $9 million in its Series C financing, bringing the total round size to $23 million ALDAGEN is a biotechnology company advancing a pipeline of clinical-stage regenerative therapies. The Company has three product candidates in clinical […]
Cyntellect, Inc. announced today that it has completed a $3 million second closing on its Series D Preferred private financing transaction. Cyntellect, Inc. is a life sciences company committed to revolutionizing the use of living cells in life science research and cellular therapy. The company combines expertise in high-speed cell imaging and laser-based manipulation […]
Cyntellect, Inc. announced today that it has completed a private financing transaction providing the company $15.1 million in venture financing. Cyntellect, Inc. is a life sciences company committed to revolutionizing the use of living cells in life science research and cellular therapy. The company combines expertise in high-speed cell imaging and laser-based manipulation to […]
Novocell, Inc., a stem cell engineering company, today announced the closing of a $25 million Series C financing Novocell is a stem cell engineering company with research operations in San Diego, CA, and Athens, GA, dedicated to creating, delivering, and commercializing cell and drug therapies for diabetes and other chronic diseases. Novocell is […]
Stem Cells
BioTechnology